Page last updated: 2024-10-22

amobarbital and Heart Diseases

amobarbital has been researched along with Heart Diseases in 2 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
TAMAGNA, IG1
POINDEXTER, CA1
Buchtal, A1
Hanson, GC1
Peisach, AR1

Other Studies

2 other studies available for amobarbital and Heart Diseases

ArticleYear
A comparative evaluation of tetraethylammonium chloride and sodium amytal in patients with hypertensive cardiovascular disease.
    The American journal of the medical sciences, 1948, Volume: 215, Issue:6

    Topics: Amobarbital; Cardiovascular Diseases; Cardiovascular System; Disease; Heart Diseases; Hypertension;

1948
Transcutaneous aortovelography. Potentially useful technique in management of critically ill patients.
    British heart journal, 1976, Volume: 38, Issue:5

    Topics: Adult; Aged; Amobarbital; Aorta, Thoracic; Blood Flow Velocity; Cardiac Output; Female; Heart; Heart

1976